Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immunobiology

Non-HLA barriers to unrelated donor stem cell transplantation

Abstract

A prospective survey involving 544 searches of the US National Marrow Donor Program (NMDP) Registry was conducted to identify reasons why many patients who have apparent HLA-matched donors do not proceed to transplant. Coordinators at NMDP transplant centers, patients and referring physicians were surveyed shortly after the initial search, and follow-up surveys were sent to the coordinators as the search was ongoing. The death of the patient, worsening of the patient's medical condition and length of the search process were the most commonly cited barriers to transplantation. Other times a decision was made not to transplant through the NMDP due to the use of a donor from another source, a preference for chemotherapy or immunotherapy, hesitancy on the part of the transplant physician or patient, or because the patient did not require a transplant. Responses differed between U.S. and international cases. An unrelated donor outside the NMDP was the most common reason cited by international coordinators (46%), whereas the death of the patient was the most common reason among US coordinators (13%). The death of the patient was the second most common reason cited by international coordinators at 9%. Financial problems were listed by 41% of US coordinators as a potential barrier at the time of initial search, but only 5% indicated this as an actual barrier on a follow-up survey. Finances were cited as the most important reason 3% of the time overall, and 6% for African Americans and Asian/Pacific Islanders. Bone Marrow Transplantation (2001) 27, 581–587.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hansen JA, Clift RA, Thomas ED et al. Transplantation of marrow from an unrelated donor to a patient with acute leukemia New Engl J Med 1980 303: 1311–1318

    Article  Google Scholar 

  2. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 51: 443–447

    Article  CAS  PubMed  Google Scholar 

  3. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program New Engl J Med 1993 328: 593–602

    Article  CAS  PubMed  Google Scholar 

  4. McCullough J, Hansen J, Perkins H et al. The National Marrow Donor Program: how it works, accomplishments to date Oncology 1989 3: 63–72

    CAS  PubMed  Google Scholar 

  5. Zumwalt Admiral ER, Howe CWS . The origins and development of the National Marrow Donor Program Leukemia 1993 7: 1122

    Google Scholar 

  6. National Marrow Donor Program Standards Committee . Standards of the National Marrow Donor Program Transfus Med Rev 1993 33: 172–180

    Google Scholar 

  7. Perkins HA, Hansen JA . The US National Marrow Donor Program Am J Ped Hematol Oncol 1994 16: 30–34

    CAS  Google Scholar 

  8. Beatty P, Mori M, Milford E . Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor Transplantation 1995 60: 778–783

    Article  CAS  PubMed  Google Scholar 

  9. Switzer GE, Dew MA, Stukas AA et al. Factors associated with attrition from a national bone marrow registry Bone Marrow Transplant 1999 24: 313–319

    Article  CAS  PubMed  Google Scholar 

  10. Howe CWS, Radde-Stepaniak T . Hematopoietic cell donor registries. In: Forman SJ, Thomas ED, Blume KG (eds) Hematopoietic Cell Transplantation Blackwell Science: Malden, MA 1998 pp 503–512

    Google Scholar 

  11. Welte K . Matched unrelated transplants Sem Onc Nur 1994 10: 20–27

    Article  CAS  Google Scholar 

  12. Beatty PG, Kollman C, Howe CWS . Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program. In: Cecka M and Terasaki PI (eds) Clinical Transplants 1995 UCLA Tissue Typing Laboratory: Los Angeles 1995 pp 271–277

    Google Scholar 

  13. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation Blood 1993 82: 667–681

    Google Scholar 

  14. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 1995 86: 1606–1613

    CAS  PubMed  Google Scholar 

  15. Petersdorf EW, Longton GM, Anasetti C et al. Definition of HLA-DQ as a transplantation antigen Proc Natl Acad Sci USA 1996 93: 15358–15363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors Blood 1997 89: 1818–1823

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to extend our appreciation to the NMDP transplant center coordinators and referring physicians who took the time and effort to complete the surveys for this study. We especially want to thank the patients and their families for their willingness to share a part of their experience during a time of deep personal crisis in the hope of helping others. We are also grateful to Nancy Morgan for her assistance in the preparation of this manuscript. This work was supported by the National Marrow Donor Program in part through funding from the Health Resources and Services Administration (Contract No. 240–97–0036) and the Office of Naval Research (Cooperative Agreement Nos N00014–96–2–0016 and N00014–99–2–0006). The views expressed in this article do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the US government.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kollman, C., Weis, T., Switzer, G. et al. Non-HLA barriers to unrelated donor stem cell transplantation. Bone Marrow Transplant 27, 581–587 (2001). https://doi.org/10.1038/sj.bmt.1702845

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702845

Keywords

This article is cited by

Search

Quick links